NASDAQ:ALVR
Delisted

Allovir Stock Forecast

etoro logo Buy ALVR
*Your capital is at risk
$9.81
+0 (+0%)
At Close: Jun 17, 2025

ALVR Performance

FAQ

What is the symbol for AlloVir, Inc. Stock and on which exchange is it traded?
The symbol for AlloVir, Inc. is ALVR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell AlloVir, Inc. Stock?
AlloVir, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy AlloVir, Inc. Stock?
AlloVir, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AlloVir, Inc. Stock.

What's the current price of AlloVir, Inc. Stock?
As of the end of day on the Jun 17, 2025, the price of an AlloVir, Inc. (ALVR) share was $9.81.

What is the 52-week high and low for AlloVir, Inc. Stock?
The 52-week high for AlloVir, Inc. Stock is $10.80 and the 52-week low is $0.380.

What is the market capitalization of AlloVir, Inc. Stock?
As of the Jun 17, 2025, the market capitalization of AlloVir, Inc. is 49.475M.
Click to get the best stock tips daily for free!
ABOUT ALLOVIR, INC.
AlloVir
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Its preclinical and clinical develop...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.87% Jun 12
DHI
$146.71
3.93% Jun 10
PHM
$118.49
2.86% Jun 10
EAT
$140.46
13.06% Jun 05
TPR
$140.47
3.84% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE